Haematologica. Open access journal of the Ferrata-Storti Foundation, a no profit organization
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Haematologica. Open access journal of the Ferrata-Storti Foundation, a no profit organization
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
  • Home
  • Current Issue
  • Early view
  • Review Series
  • Archive
  • About Us
    About Haematologica Editorial Team Our Policies Advertising Rights & Permissions Contact
  • Haematologica Award
    How to participate 2025 Winners
  • Submit a Manuscript
    Author Guidelines Reviewer Guidelines Submit and Track Manuscript Track Manuscript submitted before October 1st, 2025
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Advanced filters

Real-world outcomes in refractory chronic graft-versus-host disease: the Italian multicenter experience with belumosudil (674 Online Views)

Francesca Bonifazi, Marcello Roberto, Maria Teresa Lupo Stanghellini, Patrizia Chiusolo, Nicola Polverelli, Antonella Geromin, Lucia Prezioso, Mattia Algeri, Giorgia Mancini, Giulia Prunotto, Alessandra Algarotti, Chiara Nozzoli, Michele Malagola, Nicola Mordini, Marilena Fedele, Lidia Santoro, Francesco Zallio, Luca Castagna, Alessandra Picardi, Alessandro Busca, Luisa Giaccone, Cristina Skert, Francesca Elice, Luca Facchini, Jacopo Mariotti, Antonio Pierini, Alessandro Spina, Roberta De Marchi, Dalila Salvatore, Massimo Martino, Manuela Tumino, Alessandro Rambaldi, Franco Locatelli

BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study (1739 Online Views)

Francesco Malfona, Ilaria Tanasi, Matteo Piccini, Cristina Papayannidis, Vincenzo Federico, Valentina Mancini, Elisa Roncoroni, Elisabetta Todisco, Simona Bianchi, Giulia Ciotti, Patrizia Chiusolo, Massimo Gentile, Valentina Gianfelici, Fabio Giglio, Michele Malagola, Antonino Mulé, Francesco Saraceni, Calogero Vetro, Francesco Zallio, Luca Vincenzo Cappelli, Giovanni Pizzolo, Robin Foà, Massimiliano Bonifacio, Sabina Chiaretti

Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study (4586 Online Views)

Marco Cerrano, Massimiliano Bonifacio, Matteo Olivi, Antonio Curti, Michele Malagola, Michelina Dargenio, Anna Maria Scattolin, Cristina Papayannidis, Fabio Forghieri, Carmela Gurrieri, Ilaria Tanasi, Patrizia Zappasodi, Roberta La Starza, Nicola Stefano Fracchiolla, Patrizia Chiusolo, Luisa Giaccone, Maria Ilaria Del Principe, Fabio Giglio, Marzia Defina, Claudio Favre, Carmelo Rizzari, Barbara Castella, Giovanni Pizzolo, Felicetto Ferrara, Sabina Chiaretti, Robin Foà

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis (5802 Online Views)

Sarah A. Buckley, Brent L. Wood, Megan Othus, Christopher S. Hourigan, Celalettin Ustun, Michael A. Linden, Todd E. DeFor, Michele Malagola, Chloe Anthias, Veronika Valkova, Christopher G. Kanakry, Bernd Gruhn, Francesco Buccisano, Beth Devine, Roland B. Walter

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study. (1020 Online Views)

Pier Paolo Piccaluga, Michele Malagola, Michela Rondoni, Mario Arpinati, Stefania Paolini, Anna Candoni, Renato Fanin, Emanuela Messa, Maria Teresa Pirrotta, Francesco Lauria, Giuseppe Visani, Daniele Alberti, Francesca Rancati, Vincenza Vinaccia, Domenico Russo, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli

The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients (458 Online Views)

PP Piccaluga, M Malagola, M Amabile, M Rondoni, S Paolini, F Pane, D Russo, G Visani, M Baccarani, G Martinelli

Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission (233 Online Views)

M Malagola, G Martinelli, M Rondoni, E Ottaviani, PP Piccaluga, P Ricci, G Visani, M Baccarani

Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely (243 Online Views)

G Martinelli, M Rondoni, S Buonamici, E Ottaviani, PP Piccaluga, M Malagola, M Baccarani

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome (270 Online Views)

G Martinelli, M Malagola, E Ottaviani, G Rosti, E Trabacchi, M Baccarani

Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly (296 Online Views)

PP Piccaluga, G Martinelli, M Rondoni, M Malagola, S Ronconi, G Visani, M Baccarani

Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts (367 Online Views)

G Martinelli, E Ottaviani, S Buonamici, A Isidori, G Borsaru, G Visani, PP Piccaluga, M Malagola, N Testoni, M Rondoni, G Nucifora, S Tura, M Baccarani

Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature (251 Online Views)

PP Piccaluga, G Martinelli, M Malagola, M Rondoni, M Bianchini, G Visani, M Baccarani

Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease (247 Online Views)

G Visani, PP Piccaluga, G Martinelli, M Rossi, M Malagola, M Baccarani

Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findings (188 Online Views)

G Martinelli, E Ottaviani, S Buonamici, A Isidori, M Malagola, P Piccaluga, M Baccarani

Loading...
Searching...
1 - 14 of 14 items
Navigate
  • Home
  • Current issue
  • Early view
  • Archive
  • About Haematologica
  • Editorial Team
  • Our policies
  • Contact
For Authors
  • Author Guidelines
  • Submit Manuscript
  • Track Manuscript
For Reviewers
  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
For Advertisers
  • Information For Advertising
Education
  • Review Articles
  • Guidelines Articles
Privacy
  • Cookie Policy
  • Newsletter Privacy Policy
  • Privacy Policy
More
  • Rights & Permissions

  • Web design
  • Development
Copyright © 2026 by the Ferrata Storti Foundation | Web design → | Development →
ISSN 0390-6078 print | ISSN 1592-8721 online